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Abstract. The outdoor air pollution and the insufficient hygiene of HVAC systems often result in low 
indoor air quality. The World Health Organization estimated that 50% of indoor biological 
contamination comes from the air-handling system; the air filters are sources of pollution due to the 
accumulation and proliferation of bacteria on the surface. Furthermore, the presence of indoor 
contaminants can have a negative impact on the health and well-being of the occupants, who spend 
about 80% of their time indoors. To guarantee a better indoor air quality and a lower health risks, a 
new concept of biocidal filtration has been introduced. The present paper shows the results of a 
literature review aimed at exploring how to integrate the health effects on building occupants into 
the economic benefits of an antibacterial filter. The research focuses on costs and benefits produced 
by the application of an antibacterial filter, comparing it with a traditional one. Two methods were 
applied for the assessment; the Cost Benefit Analysis and the Monte Carlo Simulation. The results 
suggested the goodness of the economic investment on biocidal filter and showed how it allows to 
achieve benefits in term of energy savings and health for the different analysed case studies. 
1 Introduction  
The indoor air quality directly affects occupants’ health 
and well-being. Indeed, a damage indoor environment is 
linked to an increase in Sick Building Syndrome (SBS) 
symptoms, respiratory diseases, sick leave, and to a 
decrease in comfort and productivity. As ASHRAE 
guidelines [1] stated, people spend about 80–90% of their 
time in enclosed spaces. For this reason, it results 
necessary to monitor and to optimize the indoor 
environmental quality (IEQ). In addition, in the revised 
Energy Performance of Buildings Directive (EPBD, 2018 
[2]) new requirements were set, including the importance 
to assure proper indoor environment in order to optimize 
health, indoor air quality and comfort levels. The revised 
EPBD underlined the need to consider not only the energy 
efficiency of a building, but also the indoor environmental 
quality, and the health and well-being of the occupants. In 
order to achieve a good IEQ it is essential to design air 
filter and Heating, Ventilating and Air Conditioning 
(HVAC) system [3]. However, the insufficient hygiene of 
HVAC often results in the low quality of indoor air. The 
World Health Organization (WHO) [4] estimated that 
50% of indoor biological contamination comes from the 
air-handling system. In addition, several studies 
discovered that HVAC system is the main source of 
pollution in indoor spaces [5, 6, 7]. As a matter of fact, 
traditional air filtration not only can reduce the outdoor to 
indoor transport of pollutants, but it also can improve the 
health and comfort of occupants and their productivity 
[8]; at the same time, it can be a source of pollution due 
to the bacterial material accumulated on the surface. To 
reduce bacterial growth in air filters is necessary to 
introduce antimicrobials agents that allow to decrease the 
level of biocontamination in the treated air [9]. In this 
way, the replacement of a traditional filter with a biocidal 
one is investigated. In detail, the purpose of the present 
paper is to show the result of a literature review aimed at 
exploring how to integrate the health effects on building 
occupants into the economic benefits of the biocidal filter. 
The study was developed toward the consultation of 
papers and books related to occupant health and by using 
Standards concerning indoor environmental comfort. The 
paper focuses on four main sections; the first one contains 
some qualitative and quantitative features of the biocidal 
filter and its bactericidal capacity on respiratory diseases. 
Section two aims at analysing the methodologies used to 
estimate the costs and the benefits of the examined air 
filters. Section three concerns the application of the 
methods described in the previous section to the different 
analysed case studies. Finally, the fourth section shows 
the results of the economic evaluation and the 
implementation of the model with a probabilistic 
approach. 
1.1 Bactericidal filter capacity on respiratory 
diseases  
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 The biocidal air filter examined is characterized by rigid 
pockets, a high particulate filtration (F7 according to 
UNI779 [10]) and a certified efficacy of antibacterial 
power (ePM1=50% according to EN 16890 [11]). 
Compared to a traditional filter, the main difference 
consists in the presence of an additional decontamination 
from airborne microbiological agents (bacteria, moulds, 
viruses, algae). In detail, the bactericidal capacity of the 
filter has been evaluated on two bacteria: Staphylococcus 
Aureus (Gram-positive) for which has emerged an 
abatement capacity of 98%, and Escherichia Coli (Gram-
negative) for which has shown an abatement of 53% after 
16 hours, until 90% after 24 hours of contact with the filter 
[12].  
The research focuses on the main respiratory diseases, 
pneumonia and meningitis, due to these tested bacteria. 
The economic benefits of antibacterial filter on the human 
health were estimated by computing both direct costs, 
related to hospitalization and antibiotic treatments, and 
indirect costs, identified with the loss of working days 
(Section 3.3 – table 4 and 5).  
They are described below the main  features of pneumonia 
and meningitis, the incidence of Staphylococcus Aureus 
and Escherichia Coli in the respiratory diseases, and the 
bactericidal capacity of the biocidal filter to remove both 
bacteria. 
The pneumonia is a disease of the respiratory system 
caused mainly by bacterial infections. Based on the 
epidemiological criteria, it can be divided in Community-
Acquired Pneumonia (CAP), contracted outside the 
hospital environment, and Hospital-Acquired Pneumonia 
(HAP), developed at the hospital whose clinical 
symptoms occur after 48 hours from the hospitalization 
[13]. Bacterial pneumonia is associated with Gram-
positive (Streptococcus pneumoniae and Staphylococcus 
aureus) and Gram-negative bacteria (Hemophilus 
influenzae, Moraxella catarrhalis, Pseudomonas 
aeruginosa, Klebsiella pneumoniae and Escherichia coli). 
In detail, the CAP is characterized by 4% of S. Aureus and 
by 2% of E. Coli; the abatement capacity of the biocidal 
filter is 4% and 2% respectively. The hospital pneumonia 
identifies 13% of S. Aureus and 8% of E. Coli; in this case 
the bactericidal filter capacity is equal to 8% and 13% 
respectively. 
The meningitis is an inflammation process that affects the 
membranes covering the brain and spinal cord and it can 
be caused by a viral or bacterial infection. The bacterial 
meningitis requires an immediate hospitalization 
treatment due to its fatal brain damage (100% of patients 
are treated in hospital). As pneumonia, it can be divided 
in Community-Acquired Meningitis (CAM) and 
Hospital-Acquired Meningitis (HAM) [14]. Both are 
influenced by 10% of S. Aureus and 6% of E. Coli; the 
abatement capacity of biocidal filter are equal to 10% and 
6% respectively.  This disease may affect a wide range of 
people independently on the age; infants, children, adults 
and also the older people. The following analysis focuses 
only on the meningitis costs that characterized the office, 
the hotel and the hospital rooms (Table 6). Whereas 
school and gymnasium are not considered, because the 
meningitis related to infants and children are not 
characterized by the presence of the bacteria mentioned 
earlier and therefore are out of scope. 
2 Methods  
2.1 Components financial feasibility 
The financial feasibility of a project, or product, is usually 
evaluated through approaches that take into account only 
the costs as parameters of the evaluation. The Life Cycle 
Cost (LCC) technique is defined by ISO 15686-5:2008 
[15] as a tool for decision support during the design phase. 
The LCC approach makes it possible to determine the 
overall cost of a project, taking into account the entire life 
cycle [16]. The scales of application of the LCC can be 
different; from the evaluation of the individual 
components of a complex system, to an entire project. 
One of the purposes of the LCC can be the evaluation of 
alternative solutions that present different investment, 
management and maintenance costs. By distinguishing 
the different cost items mentioned, the LCC formula is as 
follows (Equation 1): 
 
   (1) 
where Ci is the investment cost, Cg the running costs, Cm 
the maintenance costs, t the year when the cost occurs, N 
the number of years of the whole period considered. 
Around this purely financial concept, different techniques 
were arose introducing sustainability awareness in the 
evaluation: Life Cycle Assessment (LCA), Life Cycle 
Sustainable Assessment (LCSA), Social Life Cycle 
Assessment (SLCA). These recent developments have 
made it possible to change the paradigm of energy system 
evaluation, shifting the concept of energy efficiency 
towards socio-economic efficiency. 
2.2 Evaluation of co-benefits 
Increasingly, the attention of scientific research is moving 
towards an integrated assessment that considers not only 
financial aspects, but also socio-economic ones. The 
externalities inclusion makes it possible to determine an 
overall assessment, considering both tangible and 
intangible effects arising from a project [17, 18, 19]. In 
this study, the impacts generated by the installation of a 
biocidal filter compared to a traditional one in terms of 
reduction of health effects are mainly assessed. If the 
financial evaluation is carried out by LCC method, as 
indicated in Section 2.1, the Cost Of Illness (COI) 
technique could be used to evaluate the benefits generated 
in health terms. The COI method evaluates benefits as 
avoided costs. In accordance with the methodology, the 
effects can be clustered in direct, indirect and intangible 
costs. The direct costs cover expenditures for resources 
provided for the prevention and treatment of the same 
pathology and related diseases, specialist visits, 
haematological and serological tests, diagnostic control 
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 procedures, supportive drug therapies and 
hospitalizations. Indirect costs are attributable to 
production losses due to absence from work by the 
subjects affected. Lastly, intangible costs are associated to 
psychosocial effects, such as suffering, and discomfort 
caused by the disease. In the COI approach, direct costs 
are estimated according to a bottom-up approach, 
multiplying the epidemiological data related to a disease 
with the costs of hospitalization, medication and disease 
management arising from the literature. For the 
calculation of indirect costs, reference was made to the 
Human Capital Approach (HCA) [20], which bases the 
calculation of costs since loss of productivity at work. The 
intangible costs are those very difficult to be expressed in 
a monetary value. To estimate these costs, approaches 
based on revealed preferences techniques are used, which 
through surveys capture the consumers’ willingness to 
pay to avoid certain negative effects. In this research, we 
will focus on the evaluation of direct and indirect avoided 
costs, omitting intangible ones. 
2.3 Cost-benefit analysis framework 
Increasingly, economic evaluation has been applied in 
studies on health care and in the medical context, 
recording an increase in scientific literature [21, 22]. In 
this context, economic assessment can be defined as the 
comparative analysis of alternative actions in terms of 
costs and consequences, with the aim of improving 
resource allocation efficiency and maximizing results. 
Economic analysis is the main purpose of considering 
both benefits and costs. Several methods of economic 
evaluations have been tested in medicine; Cost-
Minimization Analysis (CMA), Cost-Benefit Analysis 
(CBA), Cost-Utility Analysis (CUA). In this study, the 
CBA approach was chosen as the basic framework, 
combined with the Cost of Illness (COI) method [23]. 
According to [24], CBA is an analytical technique that is 
used in investment decisions in order to assess the welfare 
changes attributable to alternative projects and to select 
the most profitable in terms of the society’s convenience. 
CBA is developed through subsequent steps as follows: 1) 
identification of costs and benefits of the project; 2) 
estimation of the monetary values; 3) distribution of the 
estimated costs and benefits over the time and 
construction of the cash flow; 4) definition of the discount 
rate; 5) calculation of the performance indicators. With 
specific reference to the performance economic 
indicators, the Benefit/Cost ratio (B/C) is used in this 
study [25]. B/C is calculated dividing the sum of the 
discounted incremental benefits flows by the sum of the 
discounted incremental costs flows (Equation 2), 
obtaining a dimensionless ratio: 
𝐵
𝐶
=
∑
𝐵𝑎 − 𝐵𝑏
(1 + 𝑟)𝑡
∑
𝐶𝑎 − 𝐶𝑏
(1 + 𝑟)𝑡
 
 
(2) 
where Ba is the benefits flows on the program a, where Bb 
is the benefits flows on program b, Ca is the costs flows 
of program a, Cb is the costs flows of the program b, r is 
the discount social rate and t represents the time. The B/C 
ratio aims to establish a clear relationship between 
monetary investment to achieve one project rather than 
another, and the return of impacts, translated into 
monetary terms. 
3 Application 
3.1 Case studies  
Different case studies are analysed: office, hotel and 
school building, school gym and hospital rooms. First, to 
define the number of occupants in each case study the 
minimum air flow rates required by the UNI 10339 [26] 
are analysed. Subsequently, assuming the use of the 
medium-sized for both the biocidal and traditional filter, 
the following scenarios reported in Table 1 are 
established. 
Table 1. Different case studies analysed. 
Case 
Study 
Minimum 
 air flow rate 
Number of 
occupants 
Office 11 l/s per person 67 
Hotel 11 l/s per person 67 
School 5 l/s per person 
150 (140 students; 
10 teachers) 
School 
gym 
16.5 l/s per person 
45 (43 students;  
2 teachers) 
Hospital 
Rooms 
11 l/s per person 67 
3.2 Estimate of costs 
The Life Cycle Cost (LCC) of a filtration system includes 
the initial investment and maintenance, the energy 
consumption cost and the total cost for disposing the filter. 
It can be defined as follow (Equation 3): 
LCC total = I investment + LCC energy + LCC maintenance 
+ LCC disposal 
 
(3) 
In this paragraph the global cost calculation of the 
biocidal filter is analysed, comparing it with a traditional 
one. The input data for both filters are shown in the 
following table (Table 2) [8]. Table 3 presents the annual 
costs for each component; only investment and energy 
costs are different for the two filters considered.  
Table 2. Input data used in the analysis. 
Input Data 
Parameter Assumed value 
Interest rate 6% 
Air flow 1 mᶟ/h 
Running time 6,000 hours (1 year) 
Fan efficiency 50% 
Energy Cost 0.10 €/kWh (increasing 5% per year) 
Calculation 
Period 
10 years 
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 Table 3. Annual costs for each filter. 
 
Antibacterial 
Filter 
Traditional 
Filter 
Investment Cost 200 € 80 € 
Maintenance Cost 40 €/year (no price increase) 
Disposal Cost 4 € (increasing 5% per year) 
Energy Cost (*1) 156 € 244 € 
Initial - final 
pressure 
70 -250 Pa 80-450 Pa (*2) 
Average pressure 
drops (*3) 
130 Pa 203 Pa 
(*1) The energy cost for one year is calculate as follow: [(Air 
flow)  (Average pressure drop)  (Running time)  
(Energy cost)] / [(Fan efficiency)  1000] [8] 
(*2) From EN 779:2002 [27] 
(*3) The average pressure drops for both antibacterial and 
traditional filter is calculated as follow: pinitial + (pfinal – 
pinitial)/3 [8] 
 
Annual energy, future maintenance and disposal costs 
during the useful life of the installation are discounted at 
the present value. In this way, the correction factor (CF) 
is determined as following formula (Equation 4): 
 
CF = [1 + (i – p)]-n (4) 
 
where n is the number of years, i represents the interest 
rate and p the price increase (in the case of replacement 
cost p=0). The sum of these factors, calculated for each 
year, gives the total factor used to determine the total 
discounted costs. 
 
 
 
Fig. 1. Discounted costs for each filter. 
 
Figure 1 shows the incidence of each discounted cost. It 
is evidence that the energy cost for air filters is the most 
dominant factor of an LCC calculation (about 71% for 
antibacterial filter and 86% for traditional one). From this 
comparative analysis the antibacterial filter has a higher 
investment cost but at the same time a higher energy 
saving due to the lower fall in average pressure. 
Maintenance and disposal costs remain unchanged for 
both filters. 
3.3 An integrated CBA model to support decision 
making in HVAC system 
A probabilistic COI model is developed in order to 
estimate an aggregate measure of the economic burden 
associated with respiratory diseases related to pneumonia 
and meningitis, in terms of direct and indirect costs. The 
Staphylococcus Aureus and other infectious agents of 
Gram-negative bacterial origin, Escherichia Coli, are the 
main responsible for the CAP and HAP (Section 1.1). [28] 
has estimated that 9 adults in 1000 per year and 11-16 
children per 1000 per year get CAP pneumonia.  
Treatment of CAP pneumonia may require treatment 
based on antibiotic intake (outpatient treatment) or may 
require hospitalization for a range of cases ranging from 
8% to 51%. Pneumonia involves a large number of 
hospitalizations, which commit significant financial 
resources to National Health Services (NHS), as shown in 
Table 3. The duration of the hospital therapy requires 10 
days and demands different treatments according to the 
evaluation of clinical severity. In Italy, about 50% of 
pneumonia in adults falls into complications (CC) 
requiring more expensive treatments [29].  
From 5 to 10 cases of HAP occur every 1000 people 
admitted to hospital. Unlike CAP pneumonia, HAP also 
affects patients aged under 17, with an incidence of 17%. 
This involves an extension of the hospitalization period. 
The hospitalization rates of cases of meningitis are lower 
than those of pneumonia, recording 3-6 cases per year for 
every 100,000 inhabitants.  
From 1 to 6 cases per year, every 500-1000 hospitalized 
persons are likely to be suffering from meningitis. 
Staphylococcus Aureus and other Gram-negative bacteria 
are responsible for cases of meningitis. The treatment 
required for meningitis is hospitalization, for an average 
duration of 10 days. Hospitalization periods determine 
indirect impacts that the COI method takes into account 
in the evaluation. The most obvious impact is the absence 
of work, which can be translated as expenditure for the 
national providential system. 
 
Table 4. Parameters for direct health costs associated with 
pneumonia and meningitis [30,  31,  32]. 
Direct costs per patient € 
Cost of antibiotic treatment to cure 
pneumonia (*1) 
37.50 
Cost for outpatient management for 
pneumonia 
182 
Cost of hospitalization for pneumonia with 
complications (CC) for adults (> 17 years 
old) per day 
3,558 
Cost of hospitalization for pneumonia 
without complications (CC) for adults (> 17 
years old) per day 
2,291 
Cost of hospitalization for pneumonia for 
adolescent (< 17 years old) per day 
1,948 
Cost of hospitalization for meningitis per day   8,067 
 
(*1) Antibiotic cost (6.50 €) and chest radiography cost 
(15.50 €, to be considered twice) 
Investment Energy Replacement Disposal
Traditional filter 80 2311 272 34
Antibacterial filter 200 1478 272 34
€ 0
€ 200
€ 400
€ 600
€ 800
€ 1000
€ 1200
€ 1400
€ 1600
€ 1800
€ 2000
€ 2200
€ 2400
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 Epidemiological data are the starting point for the COI 
analysis. Through an estimate of the number of 
individuals suffering from the pathology under 
examination, the resources consumed by patients in terms 
of hospitalization and/or outpatient care are estimated to 
determine the average annual cost for each individual and 
the total annual cost. The model was implemented with 
data deriving from a systematic review of the available 
literature (Table 4). The direct costs for the hospitalization 
and antibiotic treatments are calculated following the 
formula (Equation 5): 
 
Direct costs = Medical treatment cost  Abatement 
capacity  Period spent  Morbidity events       (5) 
 
where the Medical treatment cost is equal to the cost of 
antibiotic or hospitalization, the Abatement capacity is the 
biocidal filter capability to reduce bacteria responsible for 
pneumonia and meningitis, and the Period spent reflects 
the time spents in the place where the filter is installed, in 
terms of days of work, days of stay, study days and so on, 
and Morbidity events represent the disease cases in the 
investigated case study. 
 
Table 5. Parameters for indirect costs associated with workers’ 
productivity [33, 34]. 
Indirect costs per patient € 
Average gross daily wage worker in the 
tertiary sector [33] 
125 
Average gross daily wage worker in 
public administration (school) [34] 
97.54 
 
The indirect costs consider the days of work lost due to 
admission to hospital treatment. The method used is the 
HCA, following the formula (Equation 6): 
 
Indirect costs = Daily salary  Hospitalization days  
Morbidity events           (6) 
 
where the Daily salary corresponds to the wage for 
different workers according to case studies, 
Hospitalization days represent the average period of 
hospitalization to carry out the treatment. The parameters 
for the estimation of indirect costs are summarized in 
Table 5. For each patient, the average annual salary 
corresponds to € 27,500 for the case study of the office, 
hotel and room of hospitalization, while € 19,996.27 for 
educational buildings, equivalent on average to a daily fee 
of € 125 and € 97.54 before taxes, respectively. The daily 
wage is given by the average annual income divided by 
working days per year (equal to 220 effective days for the 
tertiary sector, 365 effective days for hotel, and 205 days 
for school). For the estimation of indirect costs, it is 
assumed that all subjects were in the productive age and 
employed. In the office, hotel, and hospital rooms, the 
indirect costs are calculated by referring to the value of 
the days lost by the patient. While, in the case of school 
buildings, such as the classroom and the gymnasium 
building, being the assessment based on cases of 
pneumonia on children, the indirect impacts are calculated 
as teachers’ work performance not received by the 
students. For each case study, the direct and indirect 
avoided costs due to pneumonia are calculated and, where 
applicable, due to meningitis (Table 6). 
Table 6. Total direct and indirect costs per case study. 
Case Study 
Costs due to 
pneumonia [€] 
Costs due to 
meningitis [€] 
Office 74.70 7.69 
Hotel 123.99 12.76 
School 28.05 - 
School gym 10.39 - 
Hospital 
Rooms 
627.00 797.78 
 
In the CBA, the energy savings resulting from biocidal 
installation are considered. They are determined as the 
difference between the energy costs (Table 3) of 
traditional filter and those of the antibacterial one. 
Once calculated costs and benefits, it is possible to set the 
analysis following the CBA framework. The first step is 
to distribute the costs and benefits identified, considering 
a calculation period of 10 years. The discount rate chosen 
is equal to 2%.  
4 Discussion of the results 
To consider the intrinsic variability of the data used to 
implement the model, a probabilistic approach is used. 
The CBA analysis is joined with Monte Carlo simulation, 
in order to calculate a series of possible realizations of the 
phenomenon under examination, in a probabilistic way. 
The analysis consists in considering, for each parameter 
identified in the different sources, a minimum, average 
and maximum value in a triangular distribution. 
Furthermore, the distributions were analysed performing 
200 interactions in order to obtain interval estimates of the 
main epidemiological and economic data. 
Table 7.  Monte Carlo simulation results. 
Case Study 
B/C minimum 
value 
B/C maximum 
value 
Office 14.31 21.93 
Hotel 18.41 30.35 
School 11.82 13.11 
School gym 10.23 10.59 
Hospital 
Rooms 
113.40 215.90 
Table 7 shows the results obtained from Monte Carlo 
simulation. The case study that obtains the greatest 
benefits in terms of abatement of the bacteria responsible 
for pneumonia and meningitis turns out to be the hospital 
rooms. This is mainly motivated by the prolonged 
hospitalization of patients. Thus, avoided production costs 
would be higher than in other case studies. Figure 2 
presents the variation of B/C ratio according to the 
variation of the variables’ values for the office case study. 
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Fig. 2. B/C ratio from Monte Carlo simulation for the office case 
study. 
The hospitalization rate for pneumonia is the main 
statistical parameter capable of generating the highest 
level of variation in the estimate of the B/C ratio. Indeed, 
the oscillation of this parameter between 8% and 51% 
involves high variations in direct and indirect costs, 
varying the B/C between 14.79 to 21.86. The frequency 
of events related to pneumonia is the second most relevant 
parameter; if the maximum value of 10 cases per 1000 
inhabitants is assumed, the B/C reaches a value equal to 
19.60; if we assume that the parameter takes the minimum 
value of 8 cases per 1000 inhabitants, the B/C is 17.37. 
Conclusions 
An integrated CBA model to evaluate an innovative 
antibacterial filter for HVAC system is proposed. The 
framework integrates financial and economic parameters 
in order to assess the socio-economic efficiency of the 
system component [35]. In particular, a detailed literature 
review is performed to investigate the health benefits that 
arising from biocidal filter installation. An 
epidemiological analysis is proposed in this research in 
order to establish the number of potential patients 
diagnosed with pathologies related to meningitis and 
pneumonia in various case studies. To estimate the 
benefits in terms of avoided costs, the COI approach is 
applied. According to the COI method, the study makes it 
possible to calculate the economic burden absorbed by the 
diseases, estimating a direct annual cost sustained by the 
NHS. With reference to indirect costs, the COI estimated 
the loss of productivity in monetary terms following the 
HCA. From the point of view of financial analysis, the 
calculation of energy savings achieved is considered [36, 
37]. The model confirmed the importance of installing 
filtration measures in community settings to reduce the 
health effects of pneumonia and meningitis. In all the case 
studies analysed, the antibacterial filter provides benefits 
that exceed the costs incurred compared with a traditional 
filter. In particular, the antibacterial filter is efficient in 
the hospital, where the frequency of diseases related to 
pneumonia and meningitis is frequent. In conclusion, this 
work results to be an efficient reference tool for decision 
makers in HVAC systems problem to understand the 
economic aspects generated by the installation of an 
antibacterial filter in different community and hospital 
environments. This study presents some limitations. 
Being the model based on survey data from the existing 
literature. Unfortunately, there is no data on the national 
level of all the cost and epidemiological data referring to 
pneumonia and meningitis. However, a systematic review 
of the literature, rigorously conducted following 
international guidelines, allowed to identify the most 
recent sources. To address this problem, Monte Carlo 
simulations are conducted to take into account the 
heterogeneity of the different data available, and 
obtaining results based on intervals include the unofficial 
sources used. Furthermore, the intangible costs incurred 
by patients are not taken into account in this evaluation. 
The future research perspectives aim at the 
implementation of the model of further avoided indirect 
and intangible impacts thanks to the installation of biocide 
filters [38, 39]. Further development foresees the 
simulation of additional scenarios in different fields of 
application. 
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